Innovation often begins with collaboration. When two industry leaders join forces, the benefits ripple far beyond their respective organizations. That's precisely what's happening with UCB and Domino Data Lab, a leading data science…
At UCB we have an unwavering focus on patients – every decision, every innovation and every step forward is guided by the ambition to elevate the lives of people living with severe diseases through our medicines. To advance our innovation…
Axial spondyloarthritis (axSpA) is a chronic, immune-mediated inflammatory disease that primarily affects the spine and sacroiliac joints. Symptoms can start in early adulthood and worsen over time. In some cases non-radiographic-axSpA,…
This Saturday, 3 May, people around the world will come together to recognize World AS Day and raise awareness of axial spondyloarthritis (axSpA). It will be an important opportunity to shine a light on the experiences of those living with…
In an exciting move to make patient support more accessible, UCB has partnered with smartpatient, creators of the globally popular MyTherapy mobile health app, to offer a tailored digital health companion for people living with psoriasis.…
In osteoporosis research and clinical practice, the value of real-world evidence (RWE) is increasingly acknowledged; but much of its potential remains untapped. By analyzing real-world treatment patterns, RWE provides deeper insights into…